Sharp Therapeutics Corp.
SHRX.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 956.60K | 1.99M | 3.15M | 2.02M | 3.48M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 58.60K | 77.40K | 86.20K | 132.50K | 34.30K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.02M | 2.07M | 3.24M | 2.15M | 3.52M |
|
|
|||||
| Total Current Assets | 1.02M | 2.07M | 3.24M | 2.15M | 3.52M |
| Net Property, Plant & Equipment | 920.00K | 943.20K | 968.50K | 991.40K | 1.02M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 16.70K | 16.70K | 16.70K | 16.70K | 16.70K |
| Total Assets | 1.95M | 3.03M | 4.22M | 3.16M | 4.55M |
|
|
|||||
| Total Accounts Payable | 294.50K | 209.50K | 346.80K | 367.20K | 271.70K |
| Total Accrued Expenses | 551.50K | 113.30K | 117.40K | 101.50K | 251.30K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 108.60K | 108.20K | 48.10K | 42.00K | 36.20K |
| Total Finance Division Other Current Liabilities | -- | -- | 0.00 | 2.04M | 130.70K |
| Total Other Current Liabilities | -- | -- | 0.00 | 2.04M | 130.70K |
| Total Current Liabilities | 954.60K | 431.10K | 512.30K | 2.55M | 689.80K |
|
|
|||||
| Total Current Liabilities | 954.60K | 431.10K | 512.30K | 2.55M | 689.80K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.17M | 1.18M | 1.25M | 1.27M | 1.28M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 0.00 | -- | -- | -- |
| Total Liabilities | 2.13M | 1.61M | 1.76M | 3.82M | 1.97M |
|
|
|||||
| Common Stock & APIC | 25.92M | 25.02M | 25.01M | 22.50M | 22.46M |
| Retained Earnings | -26.06M | -23.64M | -22.58M | -23.14M | -19.89M |
| Treasury Stock & Other | -37.90K | 33.90K | 26.00K | -19.90K | 6.10K |
| Total Common Equity | -176.60K | 1.42M | 2.46M | -662.70K | 2.58M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -176.60K | 1.42M | 2.46M | -662.70K | 2.58M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -176.60K | 1.42M | 2.46M | -662.70K | 2.58M |
|
|
|||||